Nivolumab-associated acute glomerulonephritis: a case report and literature review. - Wikidata - awgldk - TriplyDB

Nivolumab-associated acute glomerulonephritis: a case report and literature review.

Nivolumab-associated acute glomerulonephritis: a case report and literature review.

http://www.wikidata.org/entity/Q36201404

about

Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer.Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: a short review.A Case of IgA Nephropathy after Nivolumab Therapy for Postoperative Recurrence of Lung Squamous Cell Carcinoma.Acute Cerebellar Ataxia Induced by Nivolumab.Renal Tubular Acidosis an Adverse Effect of PD-1 Inhibitor Immunotherapy.[Adverse events of immune checkpoint inhibitors].Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future Toxicity of Checkpoint Inhibition in Advanced RCC: A Systematic Review Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency

P2860

Q38870763-785C146B-7A0C-4383-A322-465256604CCC Q42688279-51D54EEB-6FD3-4AB9-9DE4-7F847598BEA8 Q47669638-B34FC2B8-8519-4F36-B525-F3A9ED19E6A3 Q49194491-823FD500-F547-4886-BBB1-1B6AE5078FFA Q52318577-BB86D8EB-5A46-4582-9460-92B5C42AA527 Q52785516-17C7FA88-3DBB-4827-BEA8-0C14E1AAC798 Q57172529-06ED6696-06EB-44F0-BA93-F69185B03CD9 Q58585047-A17F412D-C07D-42EC-8FB7-F83B7079B36D Q58789391-4DD0EDFC-22DC-43E6-A053-D0034E4AA3E3

P2860

Nivolumab-associated acute glomerulonephritis: a case report and literature review.

http://www.wikidata.org/entity/Q36201404

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Nivolumab-associated acute glomerulonephritis: a case report and literature review.

@ast

Nivolumab-associated acute glomerulonephritis: a case report and literature review.

@en

type

label

Nivolumab-associated acute glomerulonephritis: a case report and literature review.

@ast

Nivolumab-associated acute glomerulonephritis: a case report and literature review.

@en

prefLabel

Nivolumab-associated acute glomerulonephritis: a case report and literature review.

@ast

Nivolumab-associated acute glomerulonephritis: a case report and literature review.

@en

P1433

Q36201404-8B2AF1E6-256A-4537-B772-98BFB252C30C

P1476

Q36201404-9587F2D7-9E00-434F-B65B-30D996E1F06D

P2093

Q36201404-0300400B-A6DB-4087-9CD9-B22900A40CBB

P275

Q36201404-AF07F32D-47DA-4FA7-9CE0-0494BD2E6CDC

P2860

Q36201404-0C5A186E-21D8-420B-9773-F35E5A95C2F3

Q36201404-23582A39-9BF0-4E72-B27D-BD5F71CF9F8F

Q36201404-2C987993-AB17-4AE7-BB98-5877DC9D03BC

Q36201404-2E26CF19-DF1E-49F5-973D-927A7DAF8923

Q36201404-495CE1CB-F3D5-4DDC-8C62-4F4566029936

Q36201404-662DC6D5-63A1-47C7-9AF9-9DD104EF097E

Q36201404-89FB84DD-D020-46B0-A79D-1E7F30EDCDAF

Q36201404-9455BDF1-7F20-4A0E-A95C-E0375F728FE7

Q36201404-A3730FF4-DF32-41B3-9913-64B750C8254D

Q36201404-AF7CDCCE-A317-4340-9B56-DF6AFAEF8136

P304

Q36201404-6AA03063-3893-4302-98E2-CDB43665F2C3

P31

Q36201404-3C8757EE-EE5C-499D-984C-5CB1E5398C2C

Q36201404-FDB6B319-4D64-4CBF-8FB3-21A3B69489D2

Q36201404-e2ded304-da2a-4018-aec8-86edf15c93a4

P356

Q36201404-9C6D9D41-0667-46A7-9230-C2CF1885CF62

P433

Q36201404-D98868A6-AC39-4524-99FD-0B84E1011AA0

P478

Q36201404-64BF3CF9-48A8-4CA2-9294-72597C02B990

P50

Q36201404-30B3AE0E-E928-4BA4-811E-CA7CF3B374A1

Q36201404-BE8E67E9-EE99-43C3-88A0-93E64BA6F777

P5008

Q36201404-2CCAF1FC-F9E6-4135-8C7A-68B58E52EA05

P577

Q36201404-650F3E4C-435D-44FD-8AD4-B7E37216D8B1

P698

Q36201404-2BCB7C5C-ED51-48DA-AD78-7C87CF288B26

P921

Q36201404-168853E7-DD03-42D5-B2AF-05CDA90C243A

Q36201404-3AF702EB-53F2-4E4A-9FFA-E482ACC0A84E

Q36201404-6FCE135F-7BA9-435F-8A9C-9F32C4424C2D

Q36201404-70AAC9CD-E4EA-433D-8E8B-D6DAEDF2FC44

Q36201404-845B3D87-E51B-47E8-8A1F-551FAC5DBA10

Q36201404-B2181B2E-111A-41F4-9DB9-4DA2F607BA66

Q36201404-E2784202-E452-40E7-8AA2-98B06A83F2B9

Q36201404-F62EEE4A-4494-4F03-8576-A873E5B7B73B

P932

Q36201404-EFC3D13B-744F-42A5-91B8-DEBD29514501

P356

S12882-016-0408-2

P1433

P1476

Nivolumab-associated acute glomerulonephritis: a case report and literature review

@en

P2093

Xu Zeng

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Nivolumab plus ipilimumab in advanced melanoma.

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper.

The PDL1-PD1 axis converts human TH1 cells into regulatory T cells.

Perspectives for cancer prevention with natural compounds

P304

188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12882-016-0408-2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27876011

http://www.w3.org/2001/XMLSchema#string

P921

renal cell carcinoma

kidney neoplasm

monoclonal antibody

acute kidney injury

glomerulonephritis

P932

5120473

http://www.w3.org/2001/XMLSchema#string